Regulatory mechanisms, expression levels and proliferation effects of the FUS-DDIT3 fusion oncogene in liposarcoma.
about
Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid LiposarcomaRecent translational research into targeted therapy for liposarcoma.High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth.EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway.Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses.
P2860
Regulatory mechanisms, expression levels and proliferation effects of the FUS-DDIT3 fusion oncogene in liposarcoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Regulatory mechanisms, express ...... usion oncogene in liposarcoma.
@en
type
label
Regulatory mechanisms, express ...... usion oncogene in liposarcoma.
@en
prefLabel
Regulatory mechanisms, express ...... usion oncogene in liposarcoma.
@en
P2093
P2860
P356
P1476
Regulatory mechanisms, express ...... usion oncogene in liposarcoma.
@en
P2093
Christer Thomsen
Daniel Andersson
David Svec
Emma Jonasson
Pernilla Grundevik
Setareh Safavi
Soheila Dolatabadi
P2860
P304
P356
10.1002/PATH.4700
P577
2016-02-11T00:00:00Z